Discover 109 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 109
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: 11 recruiting locations
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
LGMD R1 Natural History Study
for
Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A,
Location: 9 recruiting locations
Sponsor: Virginia Commonwealth University
Sex: All
Age: 12 - 50
Code: NCT05618080
Recruiting
Active & Responsive
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
for
Brain Metastases From Solid Tumors
Location: 5 recruiting locations
Sponsor: Radiopharm Theranostics, Ltd
Sex: All
Age: 18+
Code: NCT06777433
Phase2, Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Location: 25 recruiting locations
Sponsor: Bayer
Sex: All
Age: 0+
Code: NCT04142437
Recruiting
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.
for
Chronic Lymphocytic Leukemia
Location: 19 recruiting locations
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06524375
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: 26 recruiting locations
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
BostonGene and Exigent Genomic INsight Study
for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: 7 recruiting locations
Sponsor: BostonGene
Sex: All
Age: 18+
Code: NCT06272864
Recruiting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: 37 recruiting locations
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab